| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 333 | 2024 | 8747 | 13.290 |
Why?
|
| Amyloid beta-Protein Precursor | 121 | 2024 | 1114 | 7.670 |
Why?
|
| Amyloid beta-Peptides | 164 | 2024 | 3910 | 7.480 |
Why?
|
| Amyloid Precursor Protein Secretases | 58 | 2024 | 614 | 7.110 |
Why?
|
| Microglia | 24 | 2024 | 1374 | 2.770 |
Why?
|
| Apolipoproteins E | 40 | 2024 | 1459 | 2.310 |
Why?
|
| Presenilin-1 | 48 | 2024 | 665 | 2.150 |
Why?
|
| Genetic Predisposition to Disease | 58 | 2024 | 18048 | 2.010 |
Why?
|
| Aspartic Acid Endopeptidases | 20 | 2024 | 308 | 1.980 |
Why?
|
| Membrane Glycoproteins | 16 | 2022 | 3712 | 1.790 |
Why?
|
| Amyloid | 23 | 2024 | 854 | 1.770 |
Why?
|
| Receptors, Immunologic | 12 | 2022 | 1416 | 1.750 |
Why?
|
| Plaque, Amyloid | 23 | 2024 | 769 | 1.750 |
Why?
|
| Peptide Fragments | 49 | 2024 | 5151 | 1.710 |
Why?
|
| Genetic Linkage | 49 | 2008 | 2342 | 1.550 |
Why?
|
| Membrane Proteins | 48 | 2023 | 7880 | 1.530 |
Why?
|
| Caspases | 12 | 2008 | 881 | 1.510 |
Why?
|
| Cromolyn Sodium | 3 | 2021 | 78 | 1.460 |
Why?
|
| Isoflurane | 12 | 2012 | 384 | 1.440 |
Why?
|
| tau Proteins | 31 | 2024 | 2143 | 1.440 |
Why?
|
| Brain | 98 | 2024 | 27454 | 1.440 |
Why?
|
| Mice, Transgenic | 60 | 2024 | 9562 | 1.440 |
Why?
|
| Neurons | 53 | 2024 | 9513 | 1.340 |
Why?
|
| Neurogenesis | 8 | 2023 | 864 | 1.250 |
Why?
|
| Anesthetics, Inhalation | 13 | 2021 | 573 | 1.220 |
Why?
|
| Carrier Proteins | 17 | 2022 | 4936 | 1.180 |
Why?
|
| Nerve Tissue Proteins | 29 | 2024 | 4414 | 1.180 |
Why?
|
| Genome-Wide Association Study | 32 | 2024 | 12778 | 1.150 |
Why?
|
| Zinc | 20 | 2012 | 677 | 1.120 |
Why?
|
| Chromosomes, Human, Pair 21 | 26 | 2005 | 229 | 1.110 |
Why?
|
| Presenilin-2 | 22 | 2019 | 100 | 1.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 7 | 2007 | 277 | 1.000 |
Why?
|
| SOXD Transcription Factors | 2 | 2017 | 44 | 0.990 |
Why?
|
| Animals | 215 | 2024 | 169337 | 0.980 |
Why?
|
| Hippocampus | 20 | 2023 | 3784 | 0.970 |
Why?
|
| Mice | 130 | 2024 | 82017 | 0.950 |
Why?
|
| Copper | 23 | 2010 | 369 | 0.940 |
Why?
|
| Adaptor Proteins, Signal Transducing | 20 | 2022 | 2911 | 0.940 |
Why?
|
| Amyloidosis | 12 | 2024 | 879 | 0.930 |
Why?
|
| Phenethylamines | 3 | 2021 | 95 | 0.910 |
Why?
|
| Cell Cycle Proteins | 12 | 2022 | 3458 | 0.890 |
Why?
|
| Databases, Genetic | 9 | 2020 | 1748 | 0.880 |
Why?
|
| Disease Models, Animal | 50 | 2024 | 18362 | 0.870 |
Why?
|
| Drosophila Proteins | 7 | 2019 | 1712 | 0.870 |
Why?
|
| Cognition | 18 | 2024 | 7075 | 0.850 |
Why?
|
| Humans | 456 | 2024 | 768393 | 0.840 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2024 | 16028 | 0.830 |
Why?
|
| Mutation | 56 | 2024 | 30228 | 0.820 |
Why?
|
| Medicine, Ayurvedic | 3 | 2017 | 37 | 0.810 |
Why?
|
| Curcumin | 4 | 2023 | 97 | 0.810 |
Why?
|
| Gene Frequency | 17 | 2023 | 3617 | 0.810 |
Why?
|
| Apolipoprotein E4 | 21 | 2023 | 711 | 0.810 |
Why?
|
| Pyridazines | 3 | 2021 | 203 | 0.800 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2022 | 60 | 0.790 |
Why?
|
| Neuroprotective Agents | 5 | 2021 | 957 | 0.790 |
Why?
|
| ADAM Proteins | 3 | 2013 | 238 | 0.780 |
Why?
|
| Presenilins | 4 | 2011 | 51 | 0.750 |
Why?
|
| Neuropeptides | 3 | 2022 | 950 | 0.730 |
Why?
|
| RNA Interference | 9 | 2017 | 2836 | 0.720 |
Why?
|
| Insulysin | 6 | 2007 | 49 | 0.700 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2024 | 2475 | 0.700 |
Why?
|
| Neurofibrillary Tangles | 11 | 2021 | 459 | 0.690 |
Why?
|
| Mast Cells | 2 | 2024 | 1407 | 0.690 |
Why?
|
| Nuclear Proteins | 9 | 2022 | 5800 | 0.690 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2015 | 1967 | 0.680 |
Why?
|
| Cricetinae | 28 | 2019 | 2423 | 0.670 |
Why?
|
| alpha-Macroglobulins | 8 | 2007 | 60 | 0.660 |
Why?
|
| Neural Stem Cells | 11 | 2022 | 891 | 0.640 |
Why?
|
| Genetic Association Studies | 7 | 2020 | 2742 | 0.640 |
Why?
|
| CHO Cells | 22 | 2019 | 1380 | 0.630 |
Why?
|
| Family | 12 | 2020 | 3208 | 0.630 |
Why?
|
| Apoptosis | 19 | 2015 | 9516 | 0.630 |
Why?
|
| Gene Silencing | 6 | 2017 | 1503 | 0.630 |
Why?
|
| Drosophila | 7 | 2019 | 1514 | 0.630 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 4 | 2020 | 303 | 0.610 |
Why?
|
| Age of Onset | 23 | 2024 | 3345 | 0.610 |
Why?
|
| Genetic Loci | 7 | 2024 | 2630 | 0.610 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 572 | 0.600 |
Why?
|
| Neuroimmunomodulation | 4 | 2024 | 188 | 0.600 |
Why?
|
| Caspase 3 | 12 | 2011 | 731 | 0.570 |
Why?
|
| Endoplasmic Reticulum | 5 | 2021 | 1131 | 0.570 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2020 | 1473 | 0.560 |
Why?
|
| Axons | 5 | 2022 | 1678 | 0.560 |
Why?
|
| Nervous System Diseases | 5 | 2023 | 1664 | 0.560 |
Why?
|
| Ibuprofen | 2 | 2018 | 229 | 0.560 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 607 | 0.550 |
Why?
|
| Chromosome Mapping | 43 | 2009 | 4622 | 0.550 |
Why?
|
| Polymorphism, Genetic | 30 | 2022 | 4250 | 0.550 |
Why?
|
| Genotype | 35 | 2022 | 13042 | 0.550 |
Why?
|
| Mutation, Missense | 5 | 2014 | 2593 | 0.540 |
Why?
|
| Mind-Body Therapies | 2 | 2017 | 291 | 0.530 |
Why?
|
| Cricetulus | 16 | 2019 | 813 | 0.530 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2016 | 18 | 0.530 |
Why?
|
| Endopeptidases | 9 | 2020 | 765 | 0.530 |
Why?
|
| Blotting, Western | 25 | 2017 | 5037 | 0.530 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2019 | 176 | 0.500 |
Why?
|
| Spheroids, Cellular | 3 | 2024 | 331 | 0.500 |
Why?
|
| Enzyme Inhibitors | 10 | 2020 | 3722 | 0.490 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 156 | 0.490 |
Why?
|
| Spirituality | 2 | 2017 | 430 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2022 | 2812 | 0.480 |
Why?
|
| Phospholipase D | 1 | 2015 | 68 | 0.480 |
Why?
|
| Metals | 8 | 2008 | 713 | 0.480 |
Why?
|
| Flow Cytometry | 4 | 2024 | 5900 | 0.480 |
Why?
|
| Cognition Disorders | 15 | 2021 | 3985 | 0.470 |
Why?
|
| Pedigree | 35 | 2015 | 4544 | 0.470 |
Why?
|
| Dementia | 10 | 2024 | 2729 | 0.470 |
Why?
|
| Cells, Cultured | 35 | 2024 | 19022 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2024 | 2890 | 0.450 |
Why?
|
| Anti-Infective Agents | 2 | 2018 | 985 | 0.450 |
Why?
|
| Brain Chemistry | 9 | 2012 | 962 | 0.450 |
Why?
|
| Down Syndrome | 12 | 2024 | 915 | 0.440 |
Why?
|
| SOX Transcription Factors | 1 | 2013 | 7 | 0.440 |
Why?
|
| Aging | 17 | 2024 | 8764 | 0.430 |
Why?
|
| Genetic Variation | 10 | 2020 | 6606 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 5 | 2022 | 1094 | 0.420 |
Why?
|
| Genes | 11 | 2000 | 1824 | 0.420 |
Why?
|
| Mitochondria | 6 | 2021 | 3675 | 0.420 |
Why?
|
| Clusterin | 2 | 2011 | 72 | 0.420 |
Why?
|
| Nerve Degeneration | 5 | 2018 | 750 | 0.420 |
Why?
|
| Transfection | 24 | 2012 | 5764 | 0.420 |
Why?
|
| Protein Precursors | 14 | 1996 | 1134 | 0.400 |
Why?
|
| Clioquinol | 8 | 2010 | 23 | 0.390 |
Why?
|
| Phagocytosis | 5 | 2022 | 1530 | 0.390 |
Why?
|
| Linkage Disequilibrium | 12 | 2017 | 1998 | 0.390 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2024 | 146 | 0.390 |
Why?
|
| Enzyme Activation | 13 | 2012 | 3587 | 0.390 |
Why?
|
| Cell Culture Techniques | 7 | 2020 | 1667 | 0.390 |
Why?
|
| Alleles | 25 | 2022 | 6892 | 0.390 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 14 | 2014 | 3813 | 0.380 |
Why?
|
| Male | 142 | 2024 | 364902 | 0.380 |
Why?
|
| Cell Line, Tumor | 28 | 2024 | 17135 | 0.380 |
Why?
|
| Neuroglia | 3 | 2023 | 960 | 0.370 |
Why?
|
| Drosophila melanogaster | 3 | 2020 | 1723 | 0.370 |
Why?
|
| Metalloproteins | 3 | 2008 | 98 | 0.360 |
Why?
|
| Down-Regulation | 3 | 2023 | 2940 | 0.360 |
Why?
|
| Gene Expression | 13 | 2021 | 7598 | 0.360 |
Why?
|
| Taurochenodeoxycholic Acid | 2 | 2020 | 35 | 0.360 |
Why?
|
| Cell Count | 2 | 2010 | 1833 | 0.360 |
Why?
|
| Molecular Chaperones | 2 | 2024 | 762 | 0.360 |
Why?
|
| Aged | 95 | 2024 | 171562 | 0.350 |
Why?
|
| Calcium Channels | 6 | 2011 | 624 | 0.350 |
Why?
|
| Phenylbutyrates | 2 | 2020 | 72 | 0.350 |
Why?
|
| Astrocytes | 7 | 2024 | 1349 | 0.340 |
Why?
|
| Immunity, Innate | 7 | 2021 | 3078 | 0.340 |
Why?
|
| RNA, Messenger | 25 | 2017 | 12805 | 0.340 |
Why?
|
| Genetic Markers | 25 | 2009 | 2604 | 0.330 |
Why?
|
| Molecular Imaging | 4 | 2024 | 827 | 0.330 |
Why?
|
| Protein Transport | 8 | 2023 | 1958 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4646 | 0.330 |
Why?
|
| Chelating Agents | 10 | 2007 | 385 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 25 | 2024 | 22355 | 0.320 |
Why?
|
| Female | 135 | 2024 | 397089 | 0.320 |
Why?
|
| Inflammasomes | 2 | 2024 | 540 | 0.320 |
Why?
|
| Positron-Emission Tomography | 7 | 2024 | 6670 | 0.310 |
Why?
|
| Developmental Disabilities | 2 | 2017 | 1516 | 0.310 |
Why?
|
| Physical Chromosome Mapping | 2 | 2007 | 183 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.310 |
Why?
|
| Microtubule-Associated Proteins | 8 | 2021 | 1078 | 0.310 |
Why?
|
| Cysteine Endopeptidases | 4 | 2001 | 542 | 0.310 |
Why?
|
| Fibronectins | 3 | 2023 | 724 | 0.310 |
Why?
|
| Lipoylation | 2 | 2021 | 87 | 0.310 |
Why?
|
| Rats | 36 | 2024 | 23835 | 0.300 |
Why?
|
| Staurosporine | 5 | 2011 | 241 | 0.300 |
Why?
|
| Models, Genetic | 9 | 2024 | 3442 | 0.300 |
Why?
|
| Sterol O-Acyltransferase | 2 | 2005 | 28 | 0.300 |
Why?
|
| Receptors, LDL | 3 | 2010 | 491 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 14 | 8 | 2008 | 286 | 0.300 |
Why?
|
| Cell Line | 22 | 2024 | 15597 | 0.290 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2022 | 1889 | 0.290 |
Why?
|
| Aprotinin | 3 | 2005 | 94 | 0.290 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 1364 | 0.290 |
Why?
|
| Memory | 6 | 2020 | 2210 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 3 | 2011 | 1337 | 0.280 |
Why?
|
| Lens, Crystalline | 4 | 2020 | 387 | 0.280 |
Why?
|
| Case-Control Studies | 22 | 2024 | 22296 | 0.280 |
Why?
|
| alpha Catenin | 1 | 2007 | 37 | 0.280 |
Why?
|
| Heart | 5 | 2020 | 4449 | 0.280 |
Why?
|
| Genomics | 7 | 2024 | 5916 | 0.270 |
Why?
|
| Polymorphism, Restriction Fragment Length | 22 | 2010 | 767 | 0.270 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 133 | 0.270 |
Why?
|
| Meditation | 3 | 2020 | 257 | 0.270 |
Why?
|
| Protein Isoforms | 5 | 2022 | 1703 | 0.270 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 1421 | 0.270 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 366 | 0.260 |
Why?
|
| Calcium | 8 | 2010 | 5794 | 0.260 |
Why?
|
| Plant Extracts | 2 | 2021 | 499 | 0.260 |
Why?
|
| Homeostasis | 5 | 2012 | 3349 | 0.260 |
Why?
|
| Animals, Genetically Modified | 6 | 2020 | 1563 | 0.260 |
Why?
|
| Genome, Human | 7 | 2016 | 4450 | 0.260 |
Why?
|
| Cell Differentiation | 7 | 2020 | 11668 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 10 | 2015 | 3779 | 0.260 |
Why?
|
| Peptides | 5 | 2019 | 4353 | 0.250 |
Why?
|
| Lod Score | 14 | 2007 | 600 | 0.250 |
Why?
|
| Exercise | 2 | 2022 | 5946 | 0.250 |
Why?
|
| Protein Folding | 2 | 2010 | 872 | 0.250 |
Why?
|
| 3' Untranslated Regions | 2 | 2005 | 515 | 0.250 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 2046 | 0.240 |
Why?
|
| RNA, Small Interfering | 8 | 2015 | 3434 | 0.240 |
Why?
|
| Molecular Sequence Data | 33 | 2010 | 17626 | 0.240 |
Why?
|
| Interleukin-6 | 5 | 2021 | 3230 | 0.240 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2005 | 119 | 0.240 |
Why?
|
| Molecular Epidemiology | 2 | 2005 | 473 | 0.240 |
Why?
|
| Models, Neurological | 3 | 2015 | 1783 | 0.240 |
Why?
|
| Yoga | 2 | 2020 | 280 | 0.240 |
Why?
|
| Cataract | 5 | 2022 | 837 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2017 | 2750 | 0.230 |
Why?
|
| Endocytosis | 6 | 2011 | 959 | 0.230 |
Why?
|
| Coculture Techniques | 3 | 2024 | 1342 | 0.230 |
Why?
|
| Genetic Testing | 10 | 2019 | 3587 | 0.230 |
Why?
|
| Cat's Claw | 2 | 2021 | 2 | 0.230 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 643 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 9 | 6 | 2009 | 534 | 0.230 |
Why?
|
| Microscopy, Confocal | 4 | 2024 | 1974 | 0.230 |
Why?
|
| Transcription Factors | 5 | 2022 | 12166 | 0.230 |
Why?
|
| Models, Biological | 12 | 2024 | 9493 | 0.230 |
Why?
|
| Cathepsin D | 2 | 2001 | 59 | 0.230 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 11918 | 0.230 |
Why?
|
| Solubility | 6 | 2016 | 1085 | 0.230 |
Why?
|
| Oxidation-Reduction | 8 | 2020 | 2225 | 0.230 |
Why?
|
| Health Promotion | 1 | 2016 | 2209 | 0.230 |
Why?
|
| Hypocapnia | 1 | 2004 | 38 | 0.230 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2023 | 775 | 0.230 |
Why?
|
| Fibroblasts | 8 | 2024 | 4177 | 0.220 |
Why?
|
| Crystallins | 2 | 2020 | 75 | 0.220 |
Why?
|
| Middle Aged | 72 | 2024 | 223491 | 0.220 |
Why?
|
| Receptors, sigma | 1 | 2024 | 46 | 0.220 |
Why?
|
| Neprilysin | 2 | 2023 | 487 | 0.220 |
Why?
|
| Drug Design | 3 | 2020 | 1046 | 0.220 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2024 | 89 | 0.220 |
Why?
|
| Risk Factors | 29 | 2024 | 74962 | 0.220 |
Why?
|
| Exons | 9 | 2021 | 2392 | 0.220 |
Why?
|
| Protein Binding | 15 | 2020 | 9343 | 0.220 |
Why?
|
| Synapses | 4 | 2016 | 1766 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2021 | 14481 | 0.220 |
Why?
|
| Blood-Brain Barrier | 3 | 2024 | 1033 | 0.220 |
Why?
|
| Genome | 3 | 2023 | 1747 | 0.210 |
Why?
|
| Tauopathies | 2 | 2024 | 328 | 0.210 |
Why?
|
| Subcellular Fractions | 7 | 2016 | 527 | 0.210 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10478 | 0.210 |
Why?
|
| Aged, 80 and over | 40 | 2024 | 59686 | 0.210 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 3 | 2011 | 24 | 0.210 |
Why?
|
| Dura Mater | 1 | 2024 | 297 | 0.200 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2022 | 22 | 0.200 |
Why?
|
| Cell Death | 5 | 2018 | 1682 | 0.200 |
Why?
|
| Roseolovirus Infections | 2 | 2020 | 50 | 0.200 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 76 | 0.200 |
Why?
|
| Genetic Heterogeneity | 4 | 2020 | 737 | 0.200 |
Why?
|
| Inclusion Bodies | 3 | 2010 | 279 | 0.190 |
Why?
|
| Tomography, Optical Coherence | 4 | 2018 | 2957 | 0.190 |
Why?
|
| Immunity | 2 | 2019 | 1003 | 0.190 |
Why?
|
| Phosphorylation | 13 | 2021 | 8326 | 0.190 |
Why?
|
| Graphite | 1 | 2022 | 79 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 692 | 0.190 |
Why?
|
| Chemotaxis | 1 | 2024 | 600 | 0.190 |
Why?
|
| Peroxidase | 1 | 2024 | 609 | 0.190 |
Why?
|
| Haplotypes | 9 | 2019 | 2724 | 0.190 |
Why?
|
| Memory Disorders | 4 | 2023 | 1203 | 0.180 |
Why?
|
| Fluorine Radioisotopes | 1 | 2024 | 424 | 0.180 |
Why?
|
| Protein Kinase C-alpha | 2 | 2022 | 113 | 0.180 |
Why?
|
| Structure-Activity Relationship | 6 | 2021 | 3055 | 0.180 |
Why?
|
| Multienzyme Complexes | 3 | 2001 | 665 | 0.180 |
Why?
|
| Gliosis | 3 | 2020 | 246 | 0.180 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 386 | 0.180 |
Why?
|
| Up-Regulation | 6 | 2020 | 4142 | 0.180 |
Why?
|
| Recombination, Genetic | 8 | 1994 | 1526 | 0.180 |
Why?
|
| Amino Acid Substitution | 6 | 2011 | 1742 | 0.180 |
Why?
|
| Roseolovirus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Interleukin-1 | 3 | 2002 | 1251 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2276 | 0.170 |
Why?
|
| Macaca mulatta | 3 | 2023 | 2362 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 3 | 2000 | 1084 | 0.170 |
Why?
|
| Transcription, Genetic | 10 | 2019 | 7599 | 0.170 |
Why?
|
| Dystonic Disorders | 1 | 2024 | 354 | 0.170 |
Why?
|
| Interleukin-3 | 1 | 2021 | 425 | 0.170 |
Why?
|
| Metalloproteases | 1 | 2020 | 60 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2007 | 350 | 0.170 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 20 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 523 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 247 | 0.170 |
Why?
|
| Chromosomes, Human | 4 | 2004 | 444 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2000 | 2856 | 0.170 |
Why?
|
| Hepatolenticular Degeneration | 3 | 1994 | 73 | 0.170 |
Why?
|
| Hydrogen Peroxide | 7 | 2004 | 742 | 0.170 |
Why?
|
| Encephalitis | 1 | 2023 | 441 | 0.160 |
Why?
|
| Cytoplasm | 4 | 2017 | 1502 | 0.160 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.160 |
Why?
|
| Thiazoles | 3 | 2016 | 1542 | 0.160 |
Why?
|
| Malacoplakia | 1 | 1999 | 15 | 0.160 |
Why?
|
| Proanthocyanidins | 1 | 2019 | 20 | 0.160 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 3827 | 0.160 |
Why?
|
| Glucosyltransferases | 1 | 2019 | 94 | 0.160 |
Why?
|
| Periapical Periodontitis | 1 | 1999 | 28 | 0.160 |
Why?
|
| Macaca fascicularis | 2 | 2021 | 913 | 0.160 |
Why?
|
| Amyloidogenic Proteins | 3 | 2024 | 154 | 0.160 |
Why?
|
| Learning | 2 | 2023 | 1761 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 2056 | 0.160 |
Why?
|
| Interleukin-12 | 1 | 2021 | 577 | 0.160 |
Why?
|
| Genetics, Medical | 1 | 2001 | 334 | 0.160 |
Why?
|
| Gene Regulatory Networks | 4 | 2024 | 1753 | 0.150 |
Why?
|
| 5' Untranslated Regions | 3 | 2007 | 255 | 0.150 |
Why?
|
| Chemokines | 2 | 2021 | 962 | 0.150 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 288 | 0.150 |
Why?
|
| Trinucleotide Repeats | 1 | 2019 | 257 | 0.150 |
Why?
|
| Disease Progression | 8 | 2023 | 13646 | 0.150 |
Why?
|
| Neuropsychological Tests | 12 | 2018 | 7145 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2019 | 314 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2000 | 492 | 0.150 |
Why?
|
| Family Health | 5 | 2016 | 1255 | 0.150 |
Why?
|
| Neuromuscular Junction | 2 | 2019 | 407 | 0.150 |
Why?
|
| Encephalitis, Viral | 1 | 2018 | 59 | 0.150 |
Why?
|
| Elastin | 1 | 2019 | 299 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 14 | 2011 | 6132 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2146 | 0.150 |
Why?
|
| Inflammation Mediators | 3 | 2018 | 1890 | 0.150 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9510 | 0.150 |
Why?
|
| Recombinant Proteins | 12 | 2010 | 6510 | 0.150 |
Why?
|
| Herpesviridae | 1 | 2018 | 104 | 0.150 |
Why?
|
| Lysosomes | 2 | 2018 | 939 | 0.150 |
Why?
|
| Zinc Fingers | 1 | 2020 | 577 | 0.150 |
Why?
|
| Base Sequence | 27 | 2002 | 12422 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2008 | 344 | 0.140 |
Why?
|
| Neurofibrils | 1 | 1997 | 75 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 2127 | 0.140 |
Why?
|
| Hormones | 1 | 2021 | 870 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2023 | 905 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2023 | 1813 | 0.140 |
Why?
|
| Radiopharmaceuticals | 2 | 2024 | 2734 | 0.140 |
Why?
|
| Maze Learning | 4 | 2020 | 484 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 131 | 0.140 |
Why?
|
| Reference Values | 9 | 2013 | 4941 | 0.140 |
Why?
|
| Anesthetics, Intravenous | 2 | 2011 | 397 | 0.140 |
Why?
|
| Pyloric Antrum | 1 | 1997 | 66 | 0.140 |
Why?
|
| Cytokines | 4 | 2021 | 7445 | 0.140 |
Why?
|
| Amino Acid Sequence | 20 | 2017 | 13423 | 0.140 |
Why?
|
| Carbazoles | 1 | 2018 | 221 | 0.140 |
Why?
|
| NAD | 1 | 2021 | 618 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2024 | 414 | 0.140 |
Why?
|
| Neuralgia | 1 | 2023 | 622 | 0.140 |
Why?
|
| Monocytes | 2 | 2024 | 2595 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2021 | 10776 | 0.140 |
Why?
|
| Dendrites | 2 | 2019 | 472 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 4357 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9614 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2024 | 1067 | 0.130 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 892 | 0.130 |
Why?
|
| Coat Protein Complex I | 1 | 2016 | 37 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 776 | 0.130 |
Why?
|
| Inflammation | 6 | 2023 | 10863 | 0.130 |
Why?
|
| Cell Membrane | 6 | 2018 | 3663 | 0.130 |
Why?
|
| Heterozygote | 6 | 2023 | 2791 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 705 | 0.130 |
Why?
|
| Huntington Disease | 13 | 1993 | 1147 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 551 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2005 | 2126 | 0.130 |
Why?
|
| Ion Channels | 1 | 2021 | 1044 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2014 | 414 | 0.130 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 50 | 0.130 |
Why?
|
| Sialic Acids | 2 | 1986 | 123 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 7 | 2011 | 1319 | 0.130 |
Why?
|
| Protein Multimerization | 3 | 2016 | 971 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 8199 | 0.130 |
Why?
|
| Kinetics | 8 | 2023 | 6333 | 0.130 |
Why?
|
| Peptide Hydrolases | 3 | 2005 | 610 | 0.130 |
Why?
|
| Adult | 37 | 2024 | 223640 | 0.130 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.130 |
Why?
|
| Apolipoprotein E2 | 3 | 2007 | 134 | 0.130 |
Why?
|
| Drug Repositioning | 1 | 2018 | 244 | 0.130 |
Why?
|
| Chromosome Aberrations | 5 | 2008 | 1780 | 0.120 |
Why?
|
| Synaptotagmins | 1 | 2015 | 53 | 0.120 |
Why?
|
| Cathepsin L | 1 | 2015 | 69 | 0.120 |
Why?
|
| Drug Combinations | 2 | 2020 | 2079 | 0.120 |
Why?
|
| Residential Treatment | 1 | 2016 | 112 | 0.120 |
Why?
|
| Energy Metabolism | 2 | 2022 | 2906 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2022 | 1118 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 6 | 2017 | 4775 | 0.120 |
Why?
|
| Drug Approval | 2 | 2021 | 818 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2018 | 753 | 0.120 |
Why?
|
| Immunohistochemistry | 15 | 2015 | 11120 | 0.120 |
Why?
|
| Adenolymphoma | 2 | 1987 | 11 | 0.120 |
Why?
|
| Binding Sites | 7 | 2012 | 6017 | 0.120 |
Why?
|
| Delirium | 1 | 2006 | 1695 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1195 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2024 | 1980 | 0.120 |
Why?
|
| Mucins | 3 | 1988 | 571 | 0.120 |
Why?
|
| Insulin | 5 | 2018 | 6607 | 0.120 |
Why?
|
| Cadherins | 4 | 2010 | 906 | 0.120 |
Why?
|
| Brain Injuries | 2 | 2020 | 2059 | 0.120 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 799 | 0.120 |
Why?
|
| Transgenes | 1 | 2018 | 1015 | 0.120 |
Why?
|
| Eye Proteins | 2 | 2015 | 628 | 0.110 |
Why?
|
| HEK293 Cells | 6 | 2024 | 4291 | 0.110 |
Why?
|
| Signal Transduction | 9 | 2024 | 23631 | 0.110 |
Why?
|
| Benzene Derivatives | 1 | 2014 | 51 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1597 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2022 | 1187 | 0.110 |
Why?
|
| Propofol | 2 | 2011 | 608 | 0.110 |
Why?
|
| Anesthesia, General | 2 | 2014 | 1186 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 1998 | 878 | 0.110 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 1993 | 18 | 0.110 |
Why?
|
| Macrophages | 3 | 2019 | 5796 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2007 | 185 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2017 | 3955 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 1997 | 602 | 0.110 |
Why?
|
| Sequence Tagged Sites | 2 | 1994 | 96 | 0.110 |
Why?
|
| DNA | 23 | 2003 | 7211 | 0.110 |
Why?
|
| Myocardium | 3 | 2016 | 4788 | 0.110 |
Why?
|
| DNA Mutational Analysis | 7 | 2012 | 4120 | 0.110 |
Why?
|
| Sex Factors | 5 | 2021 | 10654 | 0.110 |
Why?
|
| Selection Bias | 1 | 2015 | 360 | 0.110 |
Why?
|
| Awareness | 1 | 2017 | 653 | 0.110 |
Why?
|
| Cytosol | 3 | 2008 | 886 | 0.110 |
Why?
|
| Precipitin Tests | 5 | 2004 | 816 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2015 | 168 | 0.110 |
Why?
|
| Postoperative Complications | 4 | 2014 | 15881 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 103 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2007 | 431 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 3520 | 0.110 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2013 | 86 | 0.110 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.100 |
Why?
|
| Age Factors | 7 | 2018 | 18471 | 0.100 |
Why?
|
| Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2012 | 9 | 0.100 |
Why?
|
| Glioma | 10 | 2011 | 3526 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1672 | 0.100 |
Why?
|
| Cohort Studies | 13 | 2024 | 41795 | 0.100 |
Why?
|
| Lipids | 2 | 2019 | 3344 | 0.100 |
Why?
|
| PC12 Cells | 5 | 2015 | 317 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12558 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2533 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 577 | 0.100 |
Why?
|
| SUMO-1 Protein | 1 | 2012 | 35 | 0.100 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 286 | 0.100 |
Why?
|
| Myofibrils | 1 | 2013 | 143 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2020 | 1731 | 0.100 |
Why?
|
| Glaucoma | 1 | 2022 | 1194 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 1682 | 0.100 |
Why?
|
| Tissue Distribution | 4 | 2024 | 2299 | 0.100 |
Why?
|
| Cell Movement | 1 | 2024 | 5215 | 0.100 |
Why?
|
| Chromosomes, Human, 4-5 | 3 | 1986 | 26 | 0.100 |
Why?
|
| COS Cells | 4 | 2016 | 1135 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 491 | 0.100 |
Why?
|
| Cosmids | 2 | 1993 | 105 | 0.100 |
Why?
|
| Phenotype | 9 | 2021 | 16721 | 0.100 |
Why?
|
| Brain Injury, Chronic | 1 | 2012 | 68 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 117 | 0.100 |
Why?
|
| Membrane Transport Proteins | 2 | 2024 | 1034 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2015 | 415 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 716 | 0.100 |
Why?
|
| Cloning, Molecular | 13 | 1996 | 4168 | 0.100 |
Why?
|
| Empathy | 1 | 2016 | 476 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3587 | 0.100 |
Why?
|
| Alternative Splicing | 3 | 2010 | 1093 | 0.100 |
Why?
|
| Proteins | 2 | 2021 | 6006 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 1986 | 526 | 0.100 |
Why?
|
| Hybrid Cells | 8 | 1994 | 421 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 747 | 0.100 |
Why?
|
| Repressor Proteins | 3 | 2000 | 2986 | 0.090 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Protease Inhibitors | 3 | 2000 | 752 | 0.090 |
Why?
|
| Cerebral Cortex | 7 | 2020 | 5831 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3731 | 0.090 |
Why?
|
| Iron | 7 | 2010 | 1814 | 0.090 |
Why?
|
| Receptors, Opioid, delta | 1 | 2011 | 48 | 0.090 |
Why?
|
| Galectin 3 | 2 | 2023 | 240 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 1993 | 326 | 0.090 |
Why?
|
| Preoperative Period | 1 | 2013 | 564 | 0.090 |
Why?
|
| Oligopeptides | 4 | 2008 | 1194 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2022 | 3981 | 0.090 |
Why?
|
| Caenorhabditis elegans | 4 | 2016 | 1467 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 520 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2000 | 841 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 3 | 2010 | 877 | 0.090 |
Why?
|
| Autophagy | 1 | 2019 | 1351 | 0.090 |
Why?
|
| Ceruloplasmin | 1 | 2010 | 57 | 0.090 |
Why?
|
| Temporal Lobe | 3 | 2013 | 1728 | 0.090 |
Why?
|
| Air Pollution | 1 | 2024 | 2363 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1042 | 0.090 |
Why?
|
| Receptors, Complement | 1 | 2011 | 254 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 8051 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2007 | 1056 | 0.090 |
Why?
|
| Life Style | 1 | 2022 | 3929 | 0.090 |
Why?
|
| Ionophores | 1 | 2010 | 108 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2015 | 752 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2012 | 929 | 0.080 |
Why?
|
| Longevity | 1 | 1997 | 1077 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2010 | 136 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2017 | 1346 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1989 | 103 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 1998 | 2886 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 283 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 3 | 2006 | 2636 | 0.080 |
Why?
|
| Pyridines | 2 | 2020 | 2889 | 0.080 |
Why?
|
| Catalysis | 3 | 2007 | 768 | 0.080 |
Why?
|
| Hexanones | 1 | 2008 | 5 | 0.080 |
Why?
|
| Risk | 2 | 2020 | 9636 | 0.080 |
Why?
|
| Heat-Shock Proteins | 3 | 2008 | 797 | 0.080 |
Why?
|
| Etoposide | 2 | 2003 | 639 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 2819 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2015 | 964 | 0.080 |
Why?
|
| Imidazoles | 2 | 2014 | 1168 | 0.080 |
Why?
|
| Species Specificity | 3 | 2015 | 2417 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2023 | 717 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3794 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 724 | 0.080 |
Why?
|
| Cholesterol | 3 | 2003 | 2912 | 0.080 |
Why?
|
| Hydroxyquinolines | 1 | 2008 | 17 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2007 | 24318 | 0.080 |
Why?
|
| Algorithms | 4 | 2022 | 14154 | 0.080 |
Why?
|
| Histocytochemistry | 4 | 1999 | 699 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 69 | 0.080 |
Why?
|
| Tunicamycin | 1 | 2008 | 109 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2022 | 1684 | 0.080 |
Why?
|
| Herpesvirus 6, Human | 2 | 2020 | 98 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 3 | 2023 | 377 | 0.080 |
Why?
|
| Blast Injuries | 1 | 2012 | 324 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1448 | 0.080 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1879 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2024 | 3804 | 0.080 |
Why?
|
| Cattle | 3 | 2015 | 3826 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2010 | 251 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3443 | 0.070 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2008 | 121 | 0.070 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 353 | 0.070 |
Why?
|
| Longitudinal Studies | 8 | 2024 | 14784 | 0.070 |
Why?
|
| Autistic Disorder | 2 | 2008 | 1240 | 0.070 |
Why?
|
| Blood Platelets | 1 | 1998 | 2476 | 0.070 |
Why?
|
| Methyl Ethers | 1 | 2009 | 196 | 0.070 |
Why?
|
| Chromosome Deletion | 4 | 2008 | 1390 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2660 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2010 | 2172 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2005 | 521 | 0.070 |
Why?
|
| Tubulin | 3 | 2023 | 695 | 0.070 |
Why?
|
| Ganglioglioma | 1 | 2007 | 36 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2007 | 30 | 0.070 |
Why?
|
| Memantine | 1 | 2008 | 111 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2005 | 1647 | 0.070 |
Why?
|
| Antibodies | 3 | 2023 | 2425 | 0.070 |
Why?
|
| Apolipoprotein E3 | 2 | 1999 | 105 | 0.070 |
Why?
|
| Extracellular Space | 2 | 2014 | 565 | 0.070 |
Why?
|
| Macromolecular Substances | 4 | 2010 | 1435 | 0.070 |
Why?
|
| Time Factors | 10 | 2011 | 40272 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7463 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 10 | 1991 | 1305 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1674 | 0.070 |
Why?
|
| Linear Models | 4 | 2013 | 5878 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3243 | 0.070 |
Why?
|
| Cell Survival | 4 | 2015 | 5792 | 0.070 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2008 | 210 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2021 | 1884 | 0.070 |
Why?
|
| Endosomes | 3 | 2023 | 525 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2004 | 2488 | 0.070 |
Why?
|
| Computer Simulation | 6 | 2023 | 6277 | 0.070 |
Why?
|
| Parkinson Disease | 3 | 2012 | 2895 | 0.070 |
Why?
|
| Amyloid Neuropathies | 1 | 2006 | 15 | 0.070 |
Why?
|
| Rectal Neoplasms | 2 | 1985 | 1188 | 0.070 |
Why?
|
| Cervix Mucus | 1 | 1986 | 18 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 185 | 0.070 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2010 | 359 | 0.070 |
Why?
|
| Neurites | 3 | 2014 | 390 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2012 | 783 | 0.060 |
Why?
|
| Dogs | 3 | 2007 | 3846 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2005 | 640 | 0.060 |
Why?
|
| Computational Biology | 1 | 2018 | 3543 | 0.060 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 4 | 1985 | 45 | 0.060 |
Why?
|
| Helminth Proteins | 2 | 1998 | 172 | 0.060 |
Why?
|
| Cystadenoma | 1 | 1986 | 77 | 0.060 |
Why?
|
| Nitrous Oxide | 1 | 2006 | 166 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 5708 | 0.060 |
Why?
|
| Autopsy | 2 | 2024 | 1013 | 0.060 |
Why?
|
| Uterine Cervical Diseases | 1 | 1986 | 75 | 0.060 |
Why?
|
| Nuclear Family | 3 | 2000 | 311 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 662 | 0.060 |
Why?
|
| Autoradiography | 2 | 2024 | 732 | 0.060 |
Why?
|
| Dimerization | 3 | 2006 | 886 | 0.060 |
Why?
|
| Veins | 1 | 1989 | 768 | 0.060 |
Why?
|
| Colonic Neoplasms | 3 | 1988 | 2544 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2010 | 2176 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2024 | 559 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2021 | 2673 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 1993 | 375 | 0.060 |
Why?
|
| Staining and Labeling | 5 | 1996 | 1081 | 0.060 |
Why?
|
| Acetylcysteine | 2 | 2008 | 262 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2005 | 242 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1020 | 0.060 |
Why?
|
| Neuroblastoma | 6 | 2021 | 1266 | 0.060 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 874 | 0.060 |
Why?
|
| Receptors, Oxidized LDL | 1 | 2004 | 2 | 0.060 |
Why?
|
| Adenoma | 2 | 1986 | 2163 | 0.060 |
Why?
|
| Pulmonary Alveoli | 2 | 1979 | 665 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1727 | 0.060 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2004 | 8 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2006 | 260 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 5 | 2001 | 1705 | 0.060 |
Why?
|
| Apolipoprotein C-I | 1 | 2024 | 14 | 0.060 |
Why?
|
| DNA, Recombinant | 8 | 1996 | 455 | 0.060 |
Why?
|
| Sweden | 3 | 2015 | 1383 | 0.060 |
Why?
|
| Halogenation | 1 | 2024 | 46 | 0.060 |
Why?
|
| Lymphatic System | 1 | 1986 | 252 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 363 | 0.060 |
Why?
|
| In Situ Hybridization | 7 | 1998 | 1905 | 0.060 |
Why?
|
| beta Catenin | 2 | 2000 | 1047 | 0.060 |
Why?
|
| Oligonucleotide Probes | 3 | 1996 | 417 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 9 | 2003 | 6085 | 0.060 |
Why?
|
| Electroporation | 1 | 2005 | 236 | 0.060 |
Why?
|
| Polyamines | 1 | 2024 | 133 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 843 | 0.060 |
Why?
|
| Edetic Acid | 2 | 1994 | 278 | 0.060 |
Why?
|
| Diazomethane | 1 | 2023 | 37 | 0.060 |
Why?
|
| Point Mutation | 3 | 1999 | 1594 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2024 | 6856 | 0.060 |
Why?
|
| Laryngeal Neoplasms | 1 | 1987 | 515 | 0.060 |
Why?
|
| Trypsin Inhibitors | 3 | 2001 | 32 | 0.060 |
Why?
|
| Urologic Diseases | 1 | 1986 | 247 | 0.060 |
Why?
|
| Cytoskeleton | 2 | 2023 | 1176 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 160 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 9063 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 109 | 0.050 |
Why?
|
| Receptors, CCR2 | 1 | 2024 | 216 | 0.050 |
Why?
|
| Hydrocarbons, Halogenated | 2 | 2015 | 21 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 1986 | 316 | 0.050 |
Why?
|
| DNA Probes | 4 | 1992 | 542 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 2 | 2001 | 88 | 0.050 |
Why?
|
| Emulsions | 1 | 2023 | 152 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2024 | 567 | 0.050 |
Why?
|
| Body Patterning | 1 | 2007 | 634 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2024 | 420 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 1339 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.050 |
Why?
|
| Organic Chemicals | 1 | 1984 | 211 | 0.050 |
Why?
|
| Urinary Tract | 1 | 1986 | 305 | 0.050 |
Why?
|
| Microscopy | 2 | 2020 | 909 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2013 | 1421 | 0.050 |
Why?
|
| Military Personnel | 1 | 2012 | 1266 | 0.050 |
Why?
|
| Pain | 1 | 2018 | 5103 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2011 | 4031 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1984 | 294 | 0.050 |
Why?
|
| Oxidative Stress | 5 | 2010 | 3139 | 0.050 |
Why?
|
| Aqueous Humor | 1 | 2003 | 152 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1402 | 0.050 |
Why?
|
| Multigene Family | 3 | 2011 | 1082 | 0.050 |
Why?
|
| Leupeptins | 2 | 2015 | 113 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1937 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2000 | 40 | 0.050 |
Why?
|
| Logistic Models | 4 | 2016 | 13323 | 0.050 |
Why?
|
| alpha-Synuclein | 2 | 2007 | 771 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 518 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 612 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Stroke | 1 | 2024 | 9742 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2015 | 412 | 0.050 |
Why?
|
| Acyltransferases | 2 | 1994 | 306 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 2 | 2018 | 239 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2020 | 2394 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4875 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1026 | 0.050 |
Why?
|
| Butyrates | 2 | 2015 | 168 | 0.050 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 2 | 1992 | 11 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2024 | 606 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2006 | 1762 | 0.050 |
Why?
|
| Mental Health | 1 | 2016 | 3276 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5404 | 0.050 |
Why?
|
| Pericytes | 1 | 2024 | 299 | 0.050 |
Why?
|
| Neurogranin | 1 | 2021 | 15 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 567 | 0.050 |
Why?
|
| Mathematics | 2 | 1997 | 704 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 977 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2024 | 54920 | 0.050 |
Why?
|
| Butyrylcholinesterase | 1 | 2000 | 21 | 0.050 |
Why?
|
| Anxiety | 1 | 2016 | 4677 | 0.050 |
Why?
|
| ROC Curve | 2 | 2024 | 3623 | 0.050 |
Why?
|
| Postural Balance | 2 | 2020 | 639 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2020 | 12456 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2003 | 577 | 0.050 |
Why?
|
| Laminin | 2 | 2015 | 406 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6241 | 0.050 |
Why?
|
| Response Elements | 1 | 2002 | 308 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 892 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4543 | 0.050 |
Why?
|
| 3-Hydroxyanthranilic Acid | 1 | 2000 | 8 | 0.050 |
Why?
|
| Lymphocytes | 3 | 2007 | 2611 | 0.040 |
Why?
|
| Paternal Age | 2 | 1992 | 87 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2676 | 0.040 |
Why?
|
| Gene Products, tat | 1 | 2000 | 111 | 0.040 |
Why?
|
| Nondisjunction, Genetic | 2 | 1992 | 24 | 0.040 |
Why?
|
| Chromatography, Gel | 3 | 1997 | 637 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2016 | 8541 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2015 | 3612 | 0.040 |
Why?
|
| Sphingomyelins | 2 | 2016 | 105 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2008 | 2353 | 0.040 |
Why?
|
| Phototherapy | 1 | 2023 | 367 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2024 | 588 | 0.040 |
Why?
|
| Schizophrenia | 2 | 2010 | 6987 | 0.040 |
Why?
|
| Entorhinal Cortex | 1 | 2002 | 288 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 11 | 1987 | 548 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 5 | 2008 | 5801 | 0.040 |
Why?
|
| Organ Specificity | 3 | 1994 | 1967 | 0.040 |
Why?
|
| Random Allocation | 2 | 2017 | 2397 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2728 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1986 | 1110 | 0.040 |
Why?
|
| Light | 2 | 2020 | 1354 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2000 | 42 | 0.040 |
Why?
|
| Blotting, Northern | 7 | 2002 | 1553 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 244 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 155 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3464 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4076 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1999 | 65 | 0.040 |
Why?
|
| Kynurenine | 1 | 2000 | 142 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 1143 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2023 | 948 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 166 | 0.040 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 656 | 0.040 |
Why?
|
| Interneurons | 1 | 2024 | 593 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1999 | 293 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 1999 | 175 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 417 | 0.040 |
Why?
|
| Amnesia | 1 | 2001 | 258 | 0.040 |
Why?
|
| Centrifugation | 1 | 1999 | 122 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 1209 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2000 | 185 | 0.040 |
Why?
|
| Genes, Dominant | 4 | 1991 | 856 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 1987 | 3471 | 0.040 |
Why?
|
| United States | 6 | 2021 | 73150 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1986 | 957 | 0.040 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 337 | 0.040 |
Why?
|
| Cell Compartmentation | 2 | 1996 | 383 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2020 | 489 | 0.040 |
Why?
|
| Time | 1 | 2020 | 546 | 0.040 |
Why?
|
| Long-Term Potentiation | 2 | 2012 | 290 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 691 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2001 | 376 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 198 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 36849 | 0.040 |
Why?
|
| Bradycardia | 1 | 2020 | 305 | 0.040 |
Why?
|
| Filtration | 1 | 1999 | 228 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 2094 | 0.040 |
Why?
|
| Triglycerides | 1 | 2006 | 2465 | 0.040 |
Why?
|
| Iohexol | 1 | 1999 | 205 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 2862 | 0.040 |
Why?
|
| Veterans | 1 | 2012 | 2671 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2018 | 1524 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 7 | 2001 | 9261 | 0.040 |
Why?
|
| Ubiquitination | 2 | 2015 | 1009 | 0.040 |
Why?
|
| Biological Phenomena | 1 | 2018 | 28 | 0.040 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1982 | 306 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 2 | 2010 | 426 | 0.040 |
Why?
|
| Thalamus | 1 | 2024 | 1050 | 0.040 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2018 | 65 | 0.040 |
Why?
|
| Metals, Heavy | 1 | 1999 | 149 | 0.040 |
Why?
|
| Maternal Age | 2 | 1992 | 809 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 427 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1122 | 0.040 |
Why?
|
| Pseudogenes | 2 | 1994 | 104 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1493 | 0.040 |
Why?
|
| Octoxynol | 1 | 1997 | 76 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 75 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1895 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 105 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2020 | 841 | 0.040 |
Why?
|
| Isoleucine | 2 | 1998 | 112 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 521 | 0.040 |
Why?
|
| Intestines | 1 | 1986 | 1912 | 0.040 |
Why?
|
| Finland | 2 | 2009 | 609 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1248 | 0.030 |
Why?
|
| Hydrogels | 1 | 2023 | 745 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2009 | 361 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 1997 | 68 | 0.030 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 595 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 370 | 0.030 |
Why?
|
| Holidays | 1 | 2016 | 41 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15939 | 0.030 |
Why?
|
| Estradiol | 1 | 2024 | 1952 | 0.030 |
Why?
|
| Retina | 1 | 2007 | 2661 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 674 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2008 | 826 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 272 | 0.030 |
Why?
|
| Massage | 1 | 2016 | 86 | 0.030 |
Why?
|
| Biopolymers | 1 | 1997 | 183 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.030 |
Why?
|
| Epithelium | 4 | 1988 | 1609 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
| Acidosis | 1 | 1998 | 271 | 0.030 |
Why?
|
| Pupa | 1 | 2015 | 42 | 0.030 |
Why?
|
| Piperidines | 1 | 2024 | 1659 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2024 | 3164 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2016 | 167 | 0.030 |
Why?
|
| Cell Size | 1 | 2018 | 626 | 0.030 |
Why?
|
| Upstream Stimulatory Factors | 1 | 1995 | 18 | 0.030 |
Why?
|
| Titrimetry | 1 | 2015 | 36 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Receptors, Notch | 3 | 2010 | 751 | 0.030 |
Why?
|
| Synaptotagmin II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Coloring Agents | 2 | 2011 | 564 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1997 | 366 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 907 | 0.030 |
Why?
|
| Lens Diseases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Synaptotagmin I | 1 | 2015 | 33 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2012 | 1221 | 0.030 |
Why?
|
| Restriction Mapping | 3 | 1993 | 849 | 0.030 |
Why?
|
| Feedback | 1 | 1999 | 795 | 0.030 |
Why?
|
| Software | 3 | 2018 | 4453 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1976 | 107 | 0.030 |
Why?
|
| Valine | 2 | 1998 | 410 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 721 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 867 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 2 | 1985 | 53 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 650 | 0.030 |
Why?
|
| Prevalence | 2 | 2018 | 15872 | 0.030 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2015 | 38 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 2015 | 139 | 0.030 |
Why?
|
| Dopamine | 1 | 2002 | 1617 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2866 | 0.030 |
Why?
|
| Geriatrics | 1 | 1999 | 390 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 1512 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 406 | 0.030 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2015 | 89 | 0.030 |
Why?
|
| Anesthesia | 1 | 2006 | 1596 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1207 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 2016 | 181 | 0.030 |
Why?
|
| Kaolin | 1 | 1994 | 16 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1995 | 287 | 0.030 |
Why?
|
| Biodiversity | 1 | 2017 | 346 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2015 | 241 | 0.030 |
Why?
|
| Calpain | 1 | 2015 | 147 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2019 | 872 | 0.030 |
Why?
|
| Translocation, Genetic | 3 | 1989 | 1395 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2015 | 248 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2024 | 1891 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 1976 | 1998 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2007 | 108 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 369 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 1088 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2024 | 2257 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 1994 | 229 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 348 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3008 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 2002 | 900 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 475 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2426 | 0.030 |
Why?
|
| Sample Size | 1 | 1997 | 848 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Metagenome | 1 | 2017 | 465 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 190 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2006 | 9198 | 0.030 |
Why?
|
| Genes, fos | 1 | 1993 | 176 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
| Quantum Dots | 1 | 2015 | 167 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1993 | 192 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3212 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 1050 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2015 | 694 | 0.030 |
Why?
|
| Wilms Tumor | 1 | 1976 | 379 | 0.030 |
Why?
|
| Health Behavior | 1 | 2024 | 2647 | 0.030 |
Why?
|
| Internet | 2 | 2018 | 3107 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 12241 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 4570 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 1975 | 353 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 583 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 915 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 744 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
| International Cooperation | 2 | 2010 | 1438 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4588 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 968 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2069 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2012 | 119 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 1151 | 0.020 |
Why?
|
| Adolescent | 7 | 2020 | 89184 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 1992 | 92 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 2011 | 34 | 0.020 |
Why?
|
| Propidium | 1 | 2011 | 42 | 0.020 |
Why?
|
| Alanine | 1 | 2014 | 613 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1994 | 625 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 682 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1987 | 4069 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2011 | 53 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2017 | 714 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 612 | 0.020 |
Why?
|
| Chromosome Disorders | 3 | 1989 | 499 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2016 | 880 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2019 | 1813 | 0.020 |
Why?
|
| Photons | 1 | 2015 | 595 | 0.020 |
Why?
|
| Acceleration | 1 | 2012 | 190 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65379 | 0.020 |
Why?
|
| DNA, Complementary | 3 | 2005 | 1992 | 0.020 |
Why?
|
| Blotting, Southern | 4 | 1994 | 777 | 0.020 |
Why?
|
| Centromere | 1 | 1992 | 215 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 1794 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2023 | 3064 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2018 | 1142 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3431 | 0.020 |
Why?
|
| Proteomics | 1 | 2024 | 3906 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2006 | 4528 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1202 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 351 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1881 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2012 | 167 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1901 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 461 | 0.020 |
Why?
|
| Glutamates | 1 | 2011 | 385 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 258 | 0.020 |
Why?
|
| Phenanthrolines | 2 | 2000 | 49 | 0.020 |
Why?
|
| Xanthenes | 1 | 2010 | 71 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2020 | 1516 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1838 | 0.020 |
Why?
|
| Homozygote | 2 | 2012 | 1779 | 0.020 |
Why?
|
| Biological Transport | 3 | 2000 | 2085 | 0.020 |
Why?
|
| Cathelicidins | 1 | 2010 | 81 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 325 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 285 | 0.020 |
Why?
|
| Desmin | 1 | 1989 | 99 | 0.020 |
Why?
|
| Ribosomes | 1 | 1993 | 499 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 60049 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1989 | 6971 | 0.020 |
Why?
|
| Motor Activity | 1 | 2020 | 2720 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5994 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 198 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 898 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 2004 | 692 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 455 | 0.020 |
Why?
|
| Synucleins | 2 | 2001 | 108 | 0.020 |
Why?
|
| Atrophy | 2 | 2008 | 1648 | 0.020 |
Why?
|
| Body Water | 1 | 2010 | 340 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 947 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 388 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1410 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 580 | 0.020 |
Why?
|
| Chromatin | 1 | 2020 | 2968 | 0.020 |
Why?
|
| Vimentin | 1 | 1989 | 257 | 0.020 |
Why?
|
| Monosomy | 1 | 1988 | 52 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1986 | 4907 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1999 | 9379 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 505 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 1987 | 2925 | 0.020 |
Why?
|
| Anesthesia, Spinal | 1 | 2011 | 282 | 0.020 |
Why?
|
| Heart Rate | 1 | 2020 | 4218 | 0.020 |
Why?
|
| Superoxides | 2 | 2000 | 389 | 0.020 |
Why?
|
| Germany | 1 | 2011 | 882 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2017 | 9682 | 0.020 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 1988 | 27 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4273 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2010 | 489 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 1539 | 0.020 |
Why?
|
| Pilot Projects | 3 | 2011 | 8731 | 0.020 |
Why?
|
| Cerebellum | 2 | 1997 | 1514 | 0.020 |
Why?
|
| Purines | 2 | 2008 | 615 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 202 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 81801 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 274 | 0.020 |
Why?
|
| Pancreas | 1 | 1975 | 1702 | 0.020 |
Why?
|
| Liver | 1 | 1984 | 7574 | 0.020 |
Why?
|
| Oncogenes | 3 | 1988 | 1235 | 0.020 |
Why?
|
| Oxazines | 1 | 2010 | 357 | 0.020 |
Why?
|
| Tyrosine | 2 | 2004 | 1428 | 0.020 |
Why?
|
| Abdomen | 1 | 2014 | 1136 | 0.020 |
Why?
|
| RNA | 3 | 2012 | 2726 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1169 | 0.020 |
Why?
|
| Weight Gain | 1 | 2018 | 2356 | 0.020 |
Why?
|
| Lectins | 1 | 1989 | 490 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1989 | 447 | 0.020 |
Why?
|
| Hand Strength | 1 | 2010 | 466 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1926 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1988 | 387 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 2001 | 1769 | 0.020 |
Why?
|
| Space Perception | 1 | 2010 | 467 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 375 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2008 | 453 | 0.020 |
Why?
|
| MNSs Blood-Group System | 1 | 1986 | 7 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 962 | 0.020 |
Why?
|
| Benzazepines | 1 | 2008 | 311 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1988 | 174 | 0.020 |
Why?
|
| Carbamates | 1 | 2008 | 192 | 0.020 |
Why?
|
| Secretory Component | 1 | 1986 | 16 | 0.020 |
Why?
|
| Child, Preschool | 5 | 2020 | 42650 | 0.020 |
Why?
|
| Sialomucins | 1 | 1986 | 18 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3695 | 0.020 |
Why?
|
| Uterine Cervicitis | 1 | 1986 | 31 | 0.020 |
Why?
|
| Head | 1 | 2012 | 927 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1987 | 419 | 0.020 |
Why?
|
| Incidence | 1 | 2024 | 21544 | 0.020 |
Why?
|
| Intestine, Large | 1 | 1986 | 69 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 411 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1265 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 386 | 0.020 |
Why?
|
| Keratins | 1 | 1987 | 502 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1175 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1986 | 138 | 0.020 |
Why?
|
| Meiosis | 1 | 1988 | 327 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1997 | 5313 | 0.020 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 1986 | 158 | 0.020 |
Why?
|
| Telomere | 1 | 1992 | 943 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1989 | 680 | 0.020 |
Why?
|
| Actins | 2 | 1991 | 2059 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1642 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 53 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1986 | 455 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 2708 | 0.020 |
Why?
|
| China | 1 | 2011 | 2395 | 0.020 |
Why?
|
| Adenocarcinoma | 3 | 1989 | 6406 | 0.020 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1986 | 130 | 0.020 |
Why?
|
| RNA Probes | 2 | 1996 | 111 | 0.020 |
Why?
|
| Fear | 1 | 2014 | 1494 | 0.020 |
Why?
|
| Parotid Neoplasms | 1 | 1987 | 158 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1987 | 726 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2008 | 6350 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 1986 | 320 | 0.010 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1986 | 133 | 0.010 |
Why?
|
| Depression | 1 | 2024 | 8241 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1986 | 338 | 0.010 |
Why?
|
| Carcinoma | 1 | 1976 | 2341 | 0.010 |
Why?
|
| Athletes | 1 | 2012 | 1162 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2363 | 0.010 |
Why?
|
| Trace Elements | 1 | 2006 | 193 | 0.010 |
Why?
|
| Chromosome Banding | 3 | 1988 | 261 | 0.010 |
Why?
|
| Fermentation | 1 | 1964 | 142 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 1004 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26375 | 0.010 |
Why?
|
| Child | 7 | 2020 | 80891 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1989 | 1139 | 0.010 |
Why?
|
| Polyps | 1 | 1986 | 200 | 0.010 |
Why?
|
| Chloroquine | 1 | 2005 | 275 | 0.010 |
Why?
|
| Leucine | 1 | 2005 | 548 | 0.010 |
Why?
|
| Environment | 1 | 2010 | 1124 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 771 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1964 | 262 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1961 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 829 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1989 | 1493 | 0.010 |
Why?
|
| HIV-1 | 1 | 2000 | 6963 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3283 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1987 | 577 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2813 | 0.010 |
Why?
|
| Prognosis | 3 | 2008 | 30022 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 937 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8902 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 1986 | 545 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 167 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 1836 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1986 | 991 | 0.010 |
Why?
|
| Boston | 2 | 2011 | 9371 | 0.010 |
Why?
|
| Deferoxamine | 1 | 2002 | 155 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14737 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 611 | 0.010 |
Why?
|
| Organelles | 1 | 2003 | 265 | 0.010 |
Why?
|
| Iron Chelating Agents | 1 | 2002 | 141 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1986 | 605 | 0.010 |
Why?
|
| Karyotyping | 3 | 1988 | 1173 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 599 | 0.010 |
Why?
|
| Collagen | 1 | 1989 | 2646 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2001 | 247 | 0.010 |
Why?
|
| Synaptophysin | 1 | 2001 | 140 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1883 | 0.010 |
Why?
|
| Mucin-1 | 1 | 1986 | 538 | 0.010 |
Why?
|
| Executive Function | 1 | 2010 | 1405 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2001 | 184 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2000 | 91 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1226 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1486 | 0.010 |
Why?
|
| Trientine | 1 | 2000 | 12 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1986 | 561 | 0.010 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 39 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 120 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 712 | 0.010 |
Why?
|
| Brain Concussion | 1 | 2012 | 1433 | 0.010 |
Why?
|
| Calcium Channels, N-Type | 1 | 2000 | 42 | 0.010 |
Why?
|
| Tetracycline | 1 | 2001 | 216 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1825 | 0.010 |
Why?
|
| Penicillamine | 1 | 2000 | 60 | 0.010 |
Why?
|
| Open Reading Frames | 2 | 1995 | 812 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2000 | 111 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1986 | 1748 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2000 | 146 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 2825 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1976 | 4365 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 1998 | 4819 | 0.010 |
Why?
|
| Gangliosides | 1 | 2000 | 132 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1999 | 161 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2010 | 2990 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1183 | 0.010 |
Why?
|
| Epitopes | 1 | 2006 | 2525 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1999 | 45 | 0.010 |
Why?
|
| Ethylenediamines | 1 | 1999 | 57 | 0.010 |
Why?
|
| Pyramidal Tracts | 2 | 1992 | 252 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1999 | 166 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1999 | 41 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2000 | 370 | 0.010 |
Why?
|
| Histidine | 1 | 2000 | 302 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 825 | 0.010 |
Why?
|
| Ion Transport | 1 | 2000 | 322 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 440 | 0.010 |
Why?
|
| Macaca | 1 | 2000 | 417 | 0.010 |
Why?
|
| Educational Status | 1 | 2007 | 2518 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 753 | 0.010 |
Why?
|
| Selenomethionine | 2 | 1976 | 18 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1976 | 4303 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 646 | 0.010 |
Why?
|
| Aldehydes | 1 | 2000 | 170 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2000 | 242 | 0.010 |
Why?
|
| Magnesium | 1 | 2002 | 816 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 579 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1998 | 55 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 781 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1979 | 194 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 238 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.010 |
Why?
|
| Neurocytoma | 1 | 1998 | 29 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 779 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 784 | 0.010 |
Why?
|
| Technetium | 2 | 1976 | 326 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1985 | 1424 | 0.010 |
Why?
|
| Tryptophan | 1 | 2000 | 482 | 0.010 |
Why?
|
| Parietal Lobe | 2 | 1995 | 866 | 0.010 |
Why?
|
| Bradykinin | 1 | 1998 | 205 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1986 | 2204 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 927 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 1755 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2001 | 1090 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1986 | 1999 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2000 | 555 | 0.010 |
Why?
|
| Diarrhea | 1 | 1964 | 1320 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 424 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 15455 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 4427 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2000 | 508 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 1630 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 1999 | 379 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2000 | 676 | 0.010 |
Why?
|
| Glutamine | 1 | 2000 | 578 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1975 | 5443 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 692 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2000 | 658 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 1427 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3411 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 6034 | 0.010 |
Why?
|
| Parathyroid Diseases | 1 | 1976 | 46 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 923 | 0.010 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2000 | 545 | 0.010 |
Why?
|
| Wales | 2 | 1986 | 87 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20224 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 420 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1100 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 1673 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2002 | 1368 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 329 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1994 | 113 | 0.010 |
Why?
|
| Chromatography | 1 | 1994 | 189 | 0.010 |
Why?
|
| Sepharose | 1 | 1994 | 102 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1994 | 199 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2000 | 1193 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10117 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1994 | 125 | 0.010 |
Why?
|
| Cadaver | 1 | 1998 | 1366 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 1716 | 0.010 |
Why?
|
| Genomic Library | 1 | 1993 | 188 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1988 | 5099 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1998 | 780 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1986 | 2044 | 0.010 |
Why?
|
| Glycosylation | 1 | 1996 | 1100 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1994 | 2087 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 831 | 0.010 |
Why?
|
| Fetus | 1 | 2000 | 1883 | 0.010 |
Why?
|
| Water | 1 | 1999 | 1418 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1994 | 309 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 8075 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39407 | 0.010 |
Why?
|
| Rodentia | 1 | 1994 | 262 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 180 | 0.010 |
Why?
|
| Rabbits | 1 | 1979 | 4781 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1976 | 2559 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 3620 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1994 | 393 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 1216 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1994 | 405 | 0.010 |
Why?
|
| North Carolina | 1 | 1993 | 328 | 0.010 |
Why?
|
| Venezuela | 1 | 1992 | 73 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1994 | 828 | 0.010 |
Why?
|
| Clone Cells | 1 | 1995 | 1671 | 0.010 |
Why?
|
| Computers | 2 | 1989 | 592 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 3615 | 0.010 |
Why?
|
| Plasmids | 2 | 1988 | 2268 | 0.010 |
Why?
|
| Gerbillinae | 1 | 1991 | 87 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1163 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1976 | 13576 | 0.010 |
Why?
|
| Gene Library | 1 | 1994 | 1061 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2001 | 13020 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1997 | 3088 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9111 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1997 | 1609 | 0.010 |
Why?
|
| Reperfusion | 1 | 1991 | 266 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 530 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 30200 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 1988 | 33 | 0.000 |
Why?
|
| RNA, Complementary | 1 | 1988 | 46 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1988 | 142 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6430 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1997 | 2448 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1994 | 1674 | 0.000 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1987 | 14 | 0.000 |
Why?
|
| Phosphofructokinase-1 | 1 | 1987 | 50 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1985 | 9433 | 0.000 |
Why?
|
| Trisomy | 1 | 1988 | 260 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 22385 | 0.000 |
Why?
|
| Biopsy | 1 | 1979 | 6808 | 0.000 |
Why?
|
| Ligases | 1 | 1988 | 333 | 0.000 |
Why?
|
| Locus Coeruleus | 1 | 1988 | 243 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 5857 | 0.000 |
Why?
|
| DNA, Ribosomal | 1 | 1987 | 301 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1989 | 573 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1991 | 1082 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 4921 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12092 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1987 | 564 | 0.000 |
Why?
|
| Aneuploidy | 1 | 1987 | 572 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1987 | 1616 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15649 | 0.000 |
Why?
|
| Ovary | 1 | 1985 | 960 | 0.000 |
Why?
|
| Health Surveys | 1 | 1989 | 4056 | 0.000 |
Why?
|
| Syndrome | 1 | 1985 | 3275 | 0.000 |
Why?
|
| Infant | 2 | 1976 | 36510 | 0.000 |
Why?
|
| Genetic Engineering | 1 | 1985 | 936 | 0.000 |
Why?
|
| Parathyroid Neoplasms | 1 | 1976 | 244 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1984 | 3413 | 0.000 |
Why?
|
| Parents | 1 | 1988 | 3596 | 0.000 |
Why?
|